InsideTrading SEC Form 4 insider trades

Stocks

XFOR X4 Pharmaceuticals, Inc

Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $309.3M

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $0, sold $0 2022-Q2: bought $0, sold $7.6K 2022-Q3: bought $0, sold $0 2022-Q4: bought $0, sold $0 2023-Q1: bought $0, sold $166.1K 2023-Q2: bought $0, sold $72.1K 2023-Q3: bought $30.0K, sold $141.2K 2023-Q4: bought $0, sold $456.3K 2024-Q1: bought $0, sold $170.4K 2024-Q2: bought $14.7K, sold $0 2024-Q3: bought $0, sold $1.7K 2024-Q4: bought $4.6K, sold $377.0K 2025-Q1: bought $0, sold $96.4K 2025-Q2: bought $2.6K, sold $0 2025-Q3: bought $0, sold $0 2025-Q4: bought $250.0K, sold $0 2026-Q1: bought $0, sold $0 2026-Q2: bought $0, sold $109.2K 2026-Q3: bought $0, sold $320.1K 2026-Q4: bought $11.9K, sold $33.7K
Bought, above the line (largest quarter $250.0K) Plan or routine purchases (part of bought) Sold, below the line (largest quarter $456.3K)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$0$0
2022-Q2$0$7.6K
2022-Q3$0$0
2022-Q4$0$0
2023-Q1$0$166.1K
2023-Q2$0$72.1K
2023-Q3$30.0K$141.2K
2023-Q4$0$456.3K
2024-Q1$0$170.4K
2024-Q2$14.7K$0
2024-Q3$0$1.7K
2024-Q4$4.6K$377.0K
2025-Q1$0$96.4K
2025-Q2$2.6K$0
2025-Q3$0$0
2025-Q4$250.0K$0
2026-Q1$0$0
2026-Q2$0$109.2K
2026-Q3$0$320.1K
2026-Q4$11.9K$33.7K

Insider activity

Download CSV Up to 5,000 rows
Bought$313.7K6 buy days
Sold$2.0M52 sell days
Net insider flow-$1.6Mnet selling · 5 years
Latest trade2026-10-16Craig Adam R
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-10-16 Buy Craig Adam R Chair 4,600 $2.58 $11.9K 1
2026-10-01 Sell KIRSKE DAVID CFO 11,767 $2.86 $33.7K 1
2026-08-12 Sell Craig Adam R Chair 47,436 $4.44 $210.8K 1
2026-08-12 Sell Volpone John President 24,576 $4.44 $109.2K 1
2026-06-30 Sell KIRSKE DAVID CFO 8,543 $4.26 $36.4K 1
2026-05-12 Sell KIRSKE DAVID CFO 16,961 $4.29 $72.8K 1
2025-10-23 Buy Craig Adam R Chair 86,206 $2.90 $250.0K 1
2025-05-16 Buy Baldry Mark Other C-suite 1,032 $2.48 $2.6K 1
2025-01-24 Sell Ragan Paula CEO 76,473 $0.45 $34.4K 1
2025-01-24 Sell Mostafa Adam S. CFO 74,773 $0.45 $33.6K 1
2025-01-24 Sell Baldry Mark Other C-suite 29,159 $0.45 $13.1K 1
2025-01-24 Sell DiBiase Mary COO 22,258 $0.45 $10.0K 1
2025-01-24 Sell Arbet-Engels Christophe Other C-suite 11,624 $0.45 $5.2K 1
2024-11-15 Sell Ragan Paula CEO 31,897 $0.39 $12.4K 1
2024-11-15 Buy Baldry Mark Other C-suite 13,404 $0.34 $4.6K 1
2024-10-15 Sell Ragan Paula CEO 31,897 $0.56 $17.9K 1
2024-10-07 Sell Ragan Paula CEO 239,436 $0.55 $131.7K 1
2024-10-07 Sell Mostafa Adam S. CFO 230,645 $0.55 $126.9K 1
2024-10-07 Sell Taveras Arthur Other C-suite 76,920 $0.56 $43.1K 1
2024-10-07 Sell DiBiase Mary COO 67,695 $0.57 $38.6K 1
2024-10-07 Sell Baldry Mark Other C-suite 11,127 $0.58 $6.5K 1
2024-09-09 Sell DiBiase Mary COO 2,642 $0.66 $1.7K 1
2024-05-17 Buy Baldry Mark Other C-suite 21,646 $0.68 $14.7K 1
2024-03-11 Sell Mostafa Adam S. CFO 52,500 $0.88 $46.2K 1
2024-03-11 Sell Ragan Paula CEO 49,678 $0.88 $43.7K 1
2024-03-11 Sell DiBiase Mary COO 15,409 $0.88 $13.6K 1
2024-03-11 Sell Taveras Arthur Other C-suite 14,235 $0.88 $12.5K 1
2024-02-12 Sell Mostafa Adam S. CFO 27,721 $1.01 $28.0K 1
2024-02-12 Sell Ragan Paula CEO 21,695 $1.01 $21.9K 1
2024-02-12 Sell DiBiase Mary COO 3,683 $1.01 $3.7K 1
2024-02-12 Sell Taveras Arthur Other C-suite 787 $1.01 $795 1
2023-11-03 Sell Ragan Paula CEO 39,906 $0.90 $35.9K 1
2023-11-01 Sell Mostafa Adam S. CFO 230,645 $0.73 $168.4K 1
2023-11-01 Sell Ragan Paula CEO 199,531 $0.73 $145.7K 1
2023-11-01 Sell Taveras Arthur Other C-suite 67,695 $0.73 $49.4K 1
2023-11-01 Sell DiBiase Mary COO 67,695 $0.73 $49.4K 1
2023-11-01 Sell Baldry Mark Other C-suite 10,257 $0.73 $7.5K 1
2023-09-08 Sell DiBiase Mary COO 2,642 $1.25 $3.3K 1
2023-08-18 Buy WYZGA MICHAEL S Director 25,000 $1.20 $30.0K 1
2023-08-10 Sell Stewart Murray Other C-suite 130,056 $1.06 $137.9K 1
2023-06-30 Sell Mostafa Adam S. CFO 2,641 $1.89 $5.0K 1
2023-06-30 Sell DiBiase Mary COO 464 $1.89 $877 1
2023-06-23 Sell Ragan Paula CEO 6,724 $1.92 $12.9K 1
2023-06-23 Sell Mostafa Adam S. CFO 5,417 $1.93 $10.5K 1
2023-06-23 Sell DiBiase Mary COO 857 $1.93 $1.7K 1
2023-06-15 Sell Ragan Paula CEO 6,724 $2.23 $15.0K 1
2023-06-15 Sell Mostafa Adam S. CFO 5,417 $2.22 $12.0K 1
2023-06-15 Sell DiBiase Mary COO 857 $2.23 $1.9K 1
2023-05-31 Sell Ragan Paula CEO 6,292 $1.95 $12.3K 1
2023-03-10 Sell Mostafa Adam S. CFO 52,500 $0.84 $44.1K 1
2023-03-10 Sell Ragan Paula CEO 49,678 $0.84 $41.7K 1
2023-03-10 Sell DiBiase Mary COO 18,192 $0.84 $15.3K 1
2023-03-10 Sell Taveras Arthur Other C-suite 16,806 $0.84 $14.1K 1
2023-02-13 Sell Mostafa Adam S. CFO 27,721 $0.93 $25.8K 1
2023-02-13 Sell Ragan Paula CEO 21,695 $0.93 $20.2K 1
2023-02-13 Sell DiBiase Mary COO 4,348 $0.93 $4.0K 1
2023-02-13 Sell Taveras Arthur Other C-suite 928 $0.93 $863 1
2022-06-03 Sell Ragan Paula CEO 6,292 $1.21 $7.6K 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
Ragan Paula CEO $0 $553.3K 2025-01-24
Mostafa Adam S. CFO $0 $500.4K 2025-01-24
Craig Adam R Chair $261.9K $210.8K 2026-10-16
DiBiase Mary COO $0 $144.1K 2025-01-24
KIRSKE DAVID CFO $0 $142.8K 2026-10-01
Stewart Murray Other C-suite $0 $137.9K 2023-08-10
Taveras Arthur Other C-suite $0 $120.8K 2024-10-07
Volpone John President $0 $109.2K 2026-08-12
Baldry Mark Other C-suite $21.8K $27.1K 2025-05-16
WYZGA MICHAEL S Director $30.0K $0 2023-08-18
Arbet-Engels Christophe Other C-suite $0 $5.2K 2025-01-24

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2017-11-20 9 $33.2M 55 ––– closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.